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Abstract
The present study was carried out in order to determine the effect of
lung resection on the frequency of infections in alloxan-diabetic rats.
Adult female Wistar rats were injected with alloxan (40 mg/kg, iv) to
induce diabetes mellitus (group D; N = 45) or with vehicle (1.0 ml/
kg, iv) to be used as controls (group C; N = 45). Thirty-six days after
receiving alloxan both groups were randomly divided into three
subgroups: no operation (NO; N = 15), sham operation (SO; N = 15),
and left pneumonectomy (PE; N = 15). The rats were sacrificed 36
days after surgery and their lungs were examined microscopically
and macroscopically. The occurrence of thoracic wall infection,
thoracic wall abscess, lung abscess and pleural empyema was similar
in groups D and C. In contrast, the overall infection rate was higher
(P<0.05) in the diabetic rats (SO-D and PE-D subgroups, but not in
the NO-D subgroup). Considering that the overall infection rate was
similar in the SO-D and PE-D subgroups, we suggest that surgery
but not pneumonectomy was related to the higher prevalence of
infection in diabetic rats.
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Diabetic patients are more prone to infec-
tions than nondiabetic patients (1), showing
higher rates of unusual infections such as
rhinocerebral and lung mucormycosis, em-
physematous cholecystitis and pyelonephri-
tis, necrotizing cellulitis or fasciitis, and ma-
lignant external otitis (2-5). In agreement,
abnormalities of all aspects of polymorpho-
nuclear leukocyte function have been de-
scribed in diabetic patients, particularly de-
creased phagocytosis, intracellular killing,
adherence and cell movement (6,7).
Since chest surgery is very common to-
day, the possibility of a higher incidence of
infections in diabetic patients after this type
of surgery should be considered. However,
there are few studies showing the occurrence
of infections after heart (8-10) or lung sur-
gery (11) in diabetic patients. Because diabe-
tes causes higher predisposition to lung dis-
eases (12,13) and considering that lung sur-
gery is often contaminated or infected, the
possibility of an infection after lung surgery
should be considered. Thus, we investigated
the prevalence of infection in alloxan-dia-
betic rats after lung resection.
Adult female Wistar rats weighing 220 ±
20 g were used. The rats were housed at
controlled temperature (23ºC) on a 12-12-h
light-dark cycle. Water and food (Nuvital®)
were given ad libitum to all rats.
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procedures.
In order to induce diabetes, group D rats
(N = 45) were fasted for 24 h and received a
single intravenous dose (45 mg/kg) of al-
loxan. The control rats (group C, N = 45)
were 24-h fasted rats which received a single
intravenous dose of saline (1.0 ml/kg, the
same volume injected into the group D).
Immediately after the injection of alloxan or
saline all animals were maintained with free
access to food during the investigation.
Six days after the injection of alloxan or
saline, glycemia (14) was measured (always at
4 pm), and the animals with glycemia 200
mg/dl were maintained in the D group. In
addition, 36 days after the injection of alloxan,
glycemia was measured again. Similarly,
body weight was measured on days 6 and 36.
Thirty-six days after the injection of al-
loxan or saline both groups were divided
randomly into three subgroups: no operation
(NO; N = 15), sham operation (SO; N = 15),
and left pneumonectomy (PE; N = 15). On
day 36 the animals were anesthetized [2-
(2,6-xylidine)-5,6, chlorhydrate, dehydro-
4H-1,3-thiazine and ketamine chlorhydrate,
intramuscularly] and placed in a plastic box
(41 x 33 x 17 cm) with oxygen overflow
(1 liter/min) for 10 min.
The surgery was performed as described
(15), i.e., under natural ventilation, without
orotracheal intubation and with oxygen flow
(1 liter/min) through a bell glass covering the
head of the animal.
The rat was positioned in right lateral
decubitus. The left hemithorax was disin-
fected with polyvinylpyrrolidone iodine in
an aseptic environment. A left thoracotomy
was carried out in the fourth intercostal space
by an incision in the skin, subcutaneous
tissues, serratus muscle, intercostal muscles
and parietal pleura. The trunk of the left
pulmonary lobe was sutured with 000 cotton
thread and left pneumonectomy was executed
in subgroups PE-C and PE-D. In order to
keep the subatmospheric intrathoracic pres-
sure, the pleural cavity was aspirated with a
catheter and a 3-ml syringe at the junction of
the costal arches with sutures of 000 cotton
thread. In addition, thoracotomy without lung
resection, i.e., sham operation was performed
in subgroups SO-C and SO-D.
The duration of surgery was about 3-4
min which represents the maximal period of
apnea tolerated by the rat (15).
After surgery, the animals remained in
the oxygenated plastic box until they recov-
ered from anesthesia (about 30 min).
On the 36th postoperative day, the ani-
mals were anesthetized again and submitted
to laparotomy by a transverse incision in the
subcostal abdominal region. The diaphragm
muscle was released from the thoracic wall,
the costal arches were sectioned and the
anterior wall of the thorax was retracted for
inspection of the thoracic wall. Finally, the
heart was removed, the trachea and the bron-
chus were dissected and the material was
prepared for macroscopic and microscopic
analysis.
Lung fragments were selected as follows:
NO-C, SO-C, NO-D and SO-D, left lung,
cranial, medium, accessory and caudal lobes
of the right lung; PE-C and PE-D, cranial,
medium, accessory and caudal lobes of the
right lung. These fragments were immersed
in 10% formaldehyde for histological pro-
cessing by a standard technique and stained
with hematoxylin/eosin for the evaluation of
inflammatory reaction by leukocyte exudates
(neutrophils).
Microscopic parameters were scored as
present or absent and considering the in-
volvement of the anatomical area of the pleura
and/or lung: lobar pneumonia, bronchop-
neumonia, interstitial pneumonia, abscess,
and pleurisy.
Glycemia and body weight were ana-
lyzed by the paired Student t-test. The pres-
ence of infection was evaluated statistically
by the chi-square test. In addition, the pres-
ence of systemic infections was evaluated
statistically by Fisher’s test on the basis of
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the occurrence of lobar pneumonia, bron-
chopneumonia and interstitial pneumonia.
A 95% level of confidence (P<0.05) was
accepted for all comparisons. The results are
reported as means ± SD.
A single dose of alloxan (45 mg/kg) was
effective in inducing a maintained diabetic
state in all rats. Glycemia of the NO-D, SO-
D and PE-D subgroups on day 6 after alloxan
injection was 348.3 ± 44.5, 379.1 ± 66.6,
376.1 ± 74.6 mg/dl, respectively. In addi-
tion, glycemia of the NO-D, SO-D and PE-D
subgroups on day 36 after alloxan injection
was 338.3 ± 59.7, 361.5 ± 62.9 and 338.3 ±
52.9 mg/dl, respectively.
The body weight of the NO-D, SO-D and
PE-D subgroups on day 6 after alloxan injec-
tion was 218.8 ± 20.4, 203.1 ± 17.1 and
211.1 ± 19.7 g, respectively. In addition, the
body weight of the NO-D, SO-D and PE-D
subgroups on day 36 after alloxan injection
was 225.5 ± 27.7, 208.5 ± 37.7 and 219.1 ±
32.6 g, respectively. Thus, all diabetic groups
showed unchanged glycemia and body weight
from the 1st to the 36th day.
In contrast with the results of many stud-
ies showing higher susceptibility to infec-
tions (1-11,16-20), the presence of thoracic
wall infection, thoracic wall abscess, lung
abscess and pleural empyema (Table 1), and
lobar pneumonia, bronchopneumonia and
interstitial pneumonia (Table 2) did not dif-
fer between diabetic and nondiabetic rats.
Finally, group D rats (SO-D and PE-D
subgroups, but not the NO-D subgroup)
showed a higher (P<0.05) prevalence of in-
fection (Table 2). In addition, considering
that the results of overall infection rate re-
ported in Table 2 were obtained from the
other data reported in Table 2 (using Fisher’s
test), it should be emphasized that we did not
observe D rats with two or more infections.
Since the overall infection rate was simi-
lar in the SO-D and PE-D subgroups we
suggest that surgery but not pneumonectomy
was related to the higher prevalence of infec-
tion in diabetic rats.
Table 1. Thoracic wall infection, thoracic wall abscess, lung abscess and pleural
empyema in diabetic (group D) and nondiabetic (group C) rats.
Infected rats/uninfected rats Significance (C vs D)
(% infection)
Group C Group D
Thoracic wall infection
NO 0/15 (0.0) 0/15 (0.0)
SO 0/15 (0.0) 0/15 (0.0)
PE 1/14 (6.67) 0/15 (0.0) P = 0.5000
Total 1/44 (2.22) 0/45 (0.0)
Thoracic wall abscess
NO 0/15 (0.0) 0/15 (0.0)
SO 0/15 (0.0) 2/13 (13.33) P = 0.2414
PE 0/15 (0.0) 1/14 (6.67) P = 0.5000
Total 0/45 (0.0) 3/42 (6.67)
Lung abscess
NO 0/15 (0.0) 0/15 (0.0)
SO 0/15 (0.0) 0/15 (0.0)
PE 0/15 (0.0) 1/14 (6.67) P = 0.5000
Total 0/45 (0.0) 1/44 (2.22)
Pleural empyema
NO 0/15 (0.0) 0/15 (0.0)
SO 0/15 (0.0) 0/15 (0.0)
PE 0/15 (0.0) 1/14 (6.67)
Total 0/45 (0.0) 1/44 (2.22)
NO, no operation; SO, sham operation; PE, left pneumonectomy. Data were evaluated
by the chi-square test.
Table 2. Presence or absence of lobar pneumonia, bronchopneumonia, interstitial pneu-
monia and overall infection rate in diabetic (group D) and nondiabetic (group C) rats.
Infected rats/uninfected rats Significance (C vs D)
(% infection)
Group C Group D
Lobar pneumonia
NO 0/15 (0.0) 0/15 (0.0)
SO 0/15 (0.0) 2/13 (13.33) P = 0.2414
PE 0/15 (0.0) 0/15 (0.0)
Total 0/45 (0.0) 2/43 (4.44)
Bronchopneumonia
NO 0/15 (0.0) 0/15 (0.0)
SO 0/15 (0.0) 1/14 (6.67) P = 0.5000
PE 1/14 (6.67) 2/13 (13.3) P = 0.5000
Total 1/44 (2.22) 3/42 (6.67)
Interstitial pneumonia
NO 0/15 (0.0) 0/15 (0.0)
SO 0/15 (0.0) 1/14 (6.67) P = 0.5000
PE 0/15 (0.0) 2/13 (13.33) P = 0.2414
Total 0/45 (0.0) 3/42 (6.67)
Overal infection rate
NO 0/15 (0.0) 0/15 (0.0)
SO 0/15 (0.0) 6/9 (40.0) P = 0.008429
PE 2/13 (13.33) 7/8 (46.67) P = 0.005432
Total 2/43 (4.44) 13/32 (28.88)
NO, no operation; SO, sham operation; PE, left pneumonectomy. Data were evaluated
by the chi-square test, except for overall infection data that were analyzed by Fisher’s
test.
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